EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Hyaluronic Acid-Modified Redox-Responsive Gambogic Acid Prodrug Micelles for Targeted Therapy of Non-Small Cell Lung Cancer

Zhongcheng Ke, Tao Luo iD, Xiaoling Cheng, Xuwen Chai, Zitong Zhu, Zhusheng Huang, Zhen Wang

International Journal of Nanomedicine · 2026-07 · Volume 21 · 1-12

DOI: 10.2147/ijn.s616360 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2026-07. Verfasst von Zhongcheng Ke und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry and Chemical Engineering, Huangshan University, Huangshan, People's Republic of China. Hauptthemen laut MEDLINE: Xanthones, Prodrugs, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

XanthonesProdrugsCarcinoma, Non-Small-Cell LungLung NeoplasmsHyaluronic AcidAntineoplastic AgentsMicellesHumansAnimalsOxidation-ReductionMicePolyethylene GlycolsMice, NudeA549 CellsParticle SizeApoptosisCell Line, TumorXenograft Model Antitumor AssaysMice, Inbred BALB CDrug Liberation

Stichwörter der Autor:innen

gambogic acidlung cancerpolymeric prodrugredox-responsive delivery

Substanzen

Xanthonesgambogic acidMicellesProdrugsHyaluronic AcidPolyethylene GlycolsAntineoplastic Agents

Autor:innen und Institutionen

  • College of Chemistry and Chemical Engineering, Huangshan University, Huangshan, People's Republic of China.
  • Medical Experimental Center Nanjing, Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing, People's Republic of China.
  • Center for Disease Control, Tunxi Health Commission, Huangshan, People's Republic of China.
  • School of Chemistry and Life Sciences, Nanjing University of Posts and Telecommunications, Nanjing, People's Republic of China.
  • Hepatopancreatobiliary Surgery, XuZhou Central Hospital Affiliated to Southeast University, Xuzhou, People's Republic of China.

ORCID-Profile: Tao Luo

Zitieren

APA

Ke, Z., Luo, T., Cheng, X., Chai, X., Zhu, Z., Huang, Z., & Wang, Z. (2026). Hyaluronic Acid-Modified Redox-Responsive Gambogic Acid Prodrug Micelles for Targeted Therapy of Non-Small Cell Lung Cancer. International Journal of Nanomedicine, Volume 21, 1-12. https://doi.org/10.2147/ijn.s616360

Vancouver

Ke Z, Luo T, Cheng X, Chai X, Zhu Z, Huang Z, et al. Hyaluronic Acid-Modified Redox-Responsive Gambogic Acid Prodrug Micelles for Targeted Therapy of Non-Small Cell Lung Cancer. International Journal of Nanomedicine. 2026;Volume 21:1-12. doi:10.2147/ijn.s616360

BibTeX
@article{Ke2026,
  author = {Ke, Zhongcheng and Luo, Tao and Cheng, Xiaoling and Chai, Xuwen and Zhu, Zitong and Huang, Zhusheng and Wang, Zhen},
  title = {Hyaluronic Acid-Modified Redox-Responsive Gambogic Acid Prodrug Micelles for Targeted Therapy of Non-Small Cell Lung Cancer},
  journal = {International Journal of Nanomedicine},
  year = {2026},
  volume = {Volume 21},
  pages = {1--12},
  doi = {10.2147/ijn.s616360}
}
Kostenlos starten →